These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37158739)

  • 21. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.
    van Schalkwyk DA; Pratt S; Nolder D; Stewart LB; Liddy H; Muwanguzi-Karugaba J; Beshir KB; Britten D; Victory E; Rogers C; Millard J; Brown M; Nabarro LE; Taylor A; Young BC; Chiodini PL; Sutherland CJ
    Clin Infect Dis; 2024 Feb; 78(2):445-452. PubMed ID: 38019958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
    Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
    mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
    Nsobya SL; Kiggundu M; Nanyunja S; Joloba M; Greenhouse B; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1200-6. PubMed ID: 20065051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo and in vitro antiplasmodial activity and toxicity of Caesalpinia decapetala (Roth) Alston (Fabaceae).
    Ochora DO; Murithi C; Masai RJ; Abdi F; Cheruyiot A; Katuura E; Asiimwe S; Nabatanzi A; Anywar G; Oryem-Origa H; Namukobe J; Kakudidi EK; Yenesew A; Akala HM; Kamau E
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117007. PubMed ID: 37549860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance.
    He Q; Chaillet JK; Labbé F
    Elife; 2024 Feb; 12():. PubMed ID: 38363295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).
    Gendrot M; Wague Gueye M; Tsombeng Foguim F; Madamet M; Wade KA; Bou Kounta M; Fall M; Diawara S; Benoit N; Lo G; Bercion R; Amalvict R; Mosnier J; Fall B; Briolant S; Diatta B; Pradines B
    Acta Trop; 2019 Aug; 196():126-134. PubMed ID: 31108084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana.
    Aniweh Y; Soulama A; Chirawurah J; Ansah F; Danwonno HA; Sogore F; Rouillier M; Campo B; Amenga-Etego L; Djimde AA; Awandare GA; Dembele L
    Microbiol Spectr; 2023 Jun; 11(3):e0491622. PubMed ID: 37093000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.
    Mbye H; Mane K; Diop MF; Demba MA; Bojang F; Mohammed NI; Jeffries D; Quashie NB; D'Alessandro U; Amambua-Ngwa A
    J Antimicrob Chemother; 2022 Oct; 77(11):2946-2955. PubMed ID: 35904009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by
    Mbye H; Bojang F; Jawara AS; Njie B; Mohammed NI; Okebe J; D'Alessandro U; Amambua-Ngwa A
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
    Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women.
    Nayebare P; Asua V; Conrad MD; Kajubi R; Kakuru A; Nankabirwa JI; Muhanguzi D; Dorsey G; Kamya MR; Nsobya S; Rosenthal PJ
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
    L'Episcopia M; Kelley J; Patel D; Schmedes S; Ravishankar S; Menegon M; Perrotti E; Nurahmed AM; Talha AA; Nour BY; Lucchi N; Severini C; Talundzic E
    Parasit Vectors; 2020 Mar; 13(1):137. PubMed ID: 32171330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.